P. Borman

发表

Development and Validation of an in-line API Quantification Method Using AQbD Principles Based on UV-Vis Spectroscopy to Monitor and Optimise Continuous Hot Melt Extrusion Process

W. Schlindwein, D. Markl, Mariana Bezerra, 2020, Pharmaceutics.

Investigation into the factors affecting accuracy of mass measurements on a time-of-flight mass spectrometer using Design of Experiment.

Marion J. Chatfield, J. Wolff, P. Borman, 2007, Rapid communications in mass spectrometry : RCM.

Comparative performances of selected chiral HPLC, SFC, and CE systems with a chemically diverse sample set.

D. Thompson, I. Mutton, P. Borman, 2003, Chirality.

Enhanced Approaches to the Identification, Evaluation, and Control of Impurities

Jeffrey M. Kallemeyn, Matt E. Popkin, Phil J. Borman, 2018, Journal of Pharmaceutical Innovation.

Q2(R1) Validation of Analytical Procedures

Phillip Borman, David Elder, David Elder, 2017 .

Validation and robustness testing of a CEC method used to determine impurities in a pharmaceutically active compound

N. Smith, P. Borman, D. Hindocha, 2001 .

The Delivery of Flexibility from the Application of QbD to API Development

Sushil K. Srivastava, Kevin D. Seibert, Batool Ahmed Omer, 2018, Journal of Pharmaceutical Innovation.

A risk-based statistical investigation of the quantification of polymorphic purity of a pharmaceutical candidate by solid-state 19F NMR.

P. Borman, T. N. Pham, S. Watson, 2012, Analytica chimica acta.

Acceptance criteria for method equivalency assessments.

P. Borman, Phil J Borman, Marion J Chatfield, 2009, Analytical chemistry.

Design and analysis of method equivalence studies.

Marion J. Chatfield, I. Damjanov, P. Borman, 2009, Analytical chemistry.

Method ruggedness studies incorporating a risk based approach: a tutorial.

Marion J. Chatfield, I. Damjanov, P. Borman, 2011, Analytica chimica acta.

The Delivery of Flexibility from the Application of QbD to API Development

Jeffrey M. Kallemeyn, Sushil K. Srivastava, Kevin D. Seibert, 2018, Journal of Pharmaceutical Innovation.

Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).

J. Wolff, D. Elder, P. Borman, 2008, Journal of pharmaceutical and biomedical analysis.

Universal detection in high performance liquid chromatography

D. Elder, P. Borman, Okafo, 2015 .

Using the Analytical Target Profile to Drive the Analytical Method Lifecycle.

Marion J. Chatfield, T. Schofield, C. Campa, 2019, Analytical chemistry.

Toward single-calibrant quantification in HPLC. A comparison of three detection strategies: evaporative light scattering, chemiluminescent nitrogen, and proton NMR.

I. Mutton, P. Borman, Zoe Blaxill, 2005, Analytical chemistry.

Trace level impurity method development with high-field asymmetric waveform ion mobility spectrometry: systematic study of factors affecting the performance.

J. Wolff, J. Kapron, E. Champarnaud, 2009, Rapid Communications in Mass Spectrometry.

Determination of selectivity differences for basic compounds in gradient reverse phase high performance liquid chromatography under high pH conditions by partial least squares modelling.

E. Fornal, P. Borman, C. Luscombe, 2006, Analytica chimica acta.

Evaluating change during pharmaceutical product development and manufacture—comparability and equivalence

Phil J. Borman, Marion J. Chatfield, Ivana Damjanov, 2011, Qual. Reliab. Eng. Int..

Rapid Determination of Enantiomeric Excess Using Infrared Thermography

Nicolas Millot, S. Macdonald, P. Borman, 2002 .